LBCT Presentations Nicholas Marston-Evolocumab in Patients without Known Atherosclerosis and with Diabetes-Secondary Analysis from VESALIUS-CV Nicholas Marston-Essence-TIMI 73b CCTA Trial-Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis Other Presentations Nicholas Chiu-A Validation Study of Predictive Biomarkers for Diagnosis and Risk Stratification of Cardiogenic Shock among Patients Admitted to the Cardiac Intensive Care Unit Gurleen … Continue reading 2026 American College of Cardiology (New Orleans)